Skip to main content
Premium Trial:

Request an Annual Quote

Personal Genome Diagnostics' CancerSelect Targeted Gene Panel

Personal Genome Diagnostics has launched its CancerSelect targeted gene panel through its MyPersonalGenome service. The CancerSelect panel detects alterations in 88 well-characterized genes that include all targets of currently available or investigational cancer treatment options, the firm said. PGDx analyzes the CancerSelect genes using next-generation sequencing at extremely high coverage and proprietary PGDx technologies to identify a comprehensive list of genetic alterations, including point mutations, copy number alterations, and genetic rearrangements.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.